Examination about the confirmation of the efficacy at change from brand-name sustained-release oxycodone to generic sustained-release oxycodone.
Not Applicable
- Conditions
- Malignancy
- Registration Number
- JPRN-UMIN000026192
- Lead Sponsor
- Mitoyo General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Change in basal dose within two weeks before the entry, Increases or decreases in frequency of the rescue dose within two weeks before the entry, Judged inappropriate by the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umeric rating scale of cancer pain
- Secondary Outcome Measures
Name Time Method Onset of side effect